Kitas GD - Search Results

1

Association Between Uric Acid and Worsening Peripheral Microangiopathy in Systemic Sclerosis.

Pagkopoulou E, Soulaidopoulos S, Triantafyllidou E, Malliari A, Kitas GD, Garyfallos A, Dimitroulas T. Pagkopoulou E, et al. Among authors: kitas gd. Front Med (Lausanne). 2021 Dec 24;8:806925. doi: 10.3389/fmed.2021.806925. eCollection 2021. Front Med (Lausanne). 2021. PMID: 35004786 Free PMC article.

2

Biomarkers in systemic sclerosis-related pulmonary arterial hypertension.

Dimitroulas T, Giannakoulas G, Karvounis H, Settas L, Kitas GD. Dimitroulas T, et al. Among authors: kitas gd. Curr Vasc Pharmacol. 2011 Mar;9(2):213-9. doi: 10.2174/157016111794519381. Curr Vasc Pharmacol. 2011. PMID: 21143174 Review.

3

Imaging modalities for the diagnosis of pulmonary hypertension in systemic sclerosis.

Dimitroulas T, Mavrogeni S, Kitas GD. Dimitroulas T, et al. Among authors: kitas gd. Nat Rev Rheumatol. 2012 Feb 7;8(4):203-13. doi: 10.1038/nrrheum.2012.2. Nat Rev Rheumatol. 2012. PMID: 22310183 Review.

4

Systemic sclerosis-related pulmonary hypertension: unique characteristics and future treatment targets.

Dimitroulas T, Giannakoulas G, Karvounis H, Settas L, Kitas GD. Dimitroulas T, et al. Among authors: kitas gd. Curr Pharm Des. 2012;18(11):1457-64. doi: 10.2174/138161212799504704. Curr Pharm Des. 2012. PMID: 22364130 Review.

5

Lack of association between polymorphisms of thrombogenic genes and disease susceptibility in rheumatoid arthritis.

Dimitroulas T, Douglas KM, Smith J, Panoulas VF, Kitas GD. Dimitroulas T, et al. Among authors: kitas gd. Rheumatol Int. 2013 Sep;33(9):2429-32. doi: 10.1007/s00296-012-2392-6. Epub 2012 Mar 31. Rheumatol Int. 2013. PMID: 22466403

6

Multimodality imaging and the emerging role of cardiac magnetic resonance in autoimmune myocarditis.

Mavrogeni S, Dimitroulas T, Kitas GD. Mavrogeni S, et al. Among authors: kitas gd. Autoimmun Rev. 2012 Dec;12(2):305-12. doi: 10.1016/j.autrev.2012.05.005. Epub 2012 May 19. Autoimmun Rev. 2012. PMID: 22617620 Review.

7

Clinical remission following treatment with tumour necrosis factor-alpha antagonists is not accompanied by changes in asymmetric dimethylarginine in patients with rheumatoid arthritis.

Sandoo A, Dimitroulas T, Toms TE, Hodson J, Veldhuijzen van Zanten JJ, Smith JP, Kitas GD. Sandoo A, et al. Among authors: kitas gd. Clin Biochem. 2012 Nov;45(16-17):1399-403. doi: 10.1016/j.clinbiochem.2012.07.092. Epub 2012 Jul 20. Clin Biochem. 2012. PMID: 22820438

8

Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases.

Dimitroulas T, Sandoo A, Kitas GD. Dimitroulas T, et al. Among authors: kitas gd. Int J Mol Sci. 2012 Sep 26;13(10):12315-35. doi: 10.3390/ijms131012315. Int J Mol Sci. 2012. PMID: 23202900 Free PMC article. Review.

9

Biologic therapies and systemic bone loss in rheumatoid arthritis.

Dimitroulas T, Nikas SN, Trontzas P, Kitas GD. Dimitroulas T, et al. Among authors: kitas gd. Autoimmun Rev. 2013 Aug;12(10):958-66. doi: 10.1016/j.autrev.2013.03.015. Epub 2013 Mar 29. Autoimmun Rev. 2013. PMID: 23542506 Review.

10

Micro- and macrovascular treatment targets in scleroderma heart disease.

Dimitroulas T, Giannakoulas G, Karvounis H, Garyfallos A, Settas L, Kitas GD. Dimitroulas T, et al. Among authors: kitas gd. Curr Pharm Des. 2014;20(4):536-44. doi: 10.2174/13816128113199990555. Curr Pharm Des. 2014. PMID: 23565639 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

472 results

Search Page

Filters